Serve You Acquires New England Mail Order Pharmacy

Thursday, March 23, 2017 Drug News
Email Print This Page Comment
Font : A-A+

MILWAUKEE, March 22, 2017 /PRNewswire/ -- Serve You Rx Vermont, LLC, a wholly owned subsidiary of Serve You Custom Prescription

Management, Inc. (Serve You), based in Milwaukee, Wisconsin, has acquired the New England Mail Order Pharmacy (NEMOP) business, based in Middlebury, Vermont, from Pharmacy Health Services,
Inc.

"We're positioning ourselves for geographic expansion, so it was perfect timing for this opportunity to present itself," said Sharon Murillo, President and CEO of Serve You. "Like us, NEMOP has a high-touch service model, which makes it a great fit. NEMOP also brings experience in 340B, complementing our existing mail order fulfillment capabilities." 

Serve You is maintaining NEMOP's operations in Middlebury, and has retained all staff members. "We are better able to service the mail order pharmacy needs of our growing PBM membership in the New England states as a result," Murillo added.

The NEMOP acquisition comes in the midst of an expansion of Serve You's Milwaukee PBM and mail order pharmacy, Serve You DirectRx Pharmacy. When complete, Serve You DirectRx Pharmacy will have doubled its original size and quadrupled its per-shift prescription dispensing capacity. "We are making large strides in penetrating new markets around the country and are committed to growth while maintaining the service promise that Serve You is known for," said Murillo.

For more information, please visit www.serve-you-rx.com.

Media contact:Cheryl DeShamboDirector of Marketing & Product Development414-410-8164cdeshambo@serve-you-rx.com

Related Links

Company website

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/serve-you-acquires-new-england-mail-order-pharmacy-300427937.html

SOURCE Serve You



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook